IRF3 and cardiac hypertrophy: In 2011, Tsushima and coworkers reported that IRF3 knockout attenuated cardiac fibrosis and ventricular chamber shrinkage in mice infused with angiotensin II, whereas cardiac hypertrophy was unaffected (127).